Sarantis Is Fighting the Last Cost War — While Pricing Waits for Q4
Flat H1 2026 headlines hide a squeeze: Middle East fuel and logistics costs bite now, but the price increases to cover them don't land until Q4 — and global mind-share has already moved on to tariff refunds.
SAR.AT · Earnings Call · 2026-09-09
Flat Numbers, A Violent Cross-Current
Gr. Sarantis is a ~€823M-market-cap Greek consumer-defensive name that reported H1 2026 into genuinely messy conditions, and the top line shows it: net sales rose just 1.3% to €308.2M, gross margin stayed stubbornly flat at 38.6%, underlying EBITDA edged up 0.4% to €48.5M, and underlying net income slipped 5% to €27.7M. Almost eerily calm. The calm hides a violent internal cross-current — the company's own keyword board is dominated by cost pressure, a fresh top-10 entrant this quarter, alongside a new oil price reference that simply did not matter a year ago. CEO Ioannis Bouras names the driver outright: “we have some significant geopolitical challenges. Related to Middle East. This has resulted a significant cost pressure in raw materials and logistics linked with oil prices” — Ioannis K. Bouras, CEO · 2026-09-09. And the specific channel, per CFO Christos Varsos, is freight: “there is also some impact in ... transportation and transport expenses. Because of the kind of the fuel and everything else.” — Christos Varsos, CFO · 2026-09-09 So far, so macro. But the interesting twist is timing.Pressure Now, Price Later
Sarantis is absorbing cost today and only getting paid for it tomorrow. Bouras is explicit: “in Q3 ... we have the pressure from cost, but the pricing will start to hit in Q4. So, potentially, this will be a bit weak at that point.” — Ioannis K. Bouras, CEO · 2026-09-09 That means the second half likely gets worse on margin before it gets better — a setup that is easy to misread if you only glance at a flattish H1 gross margin. Mix makes it harder still. Strategic partnerships grew 4.9% (mass distribution +12%, while selective dropped 9%), and that lower-margin business is growing faster than the rest of the portfolio, diluting group margin even as management extracts synergies. Meanwhile promotional pressure — a new high-ranked company theme — hit personal care hardest, where net sales fell 2.7% and EBIT dropped 17% on a weak pregnancy-related sub-segment. One nuance worth flagging: because Bouras confirms there were no price increases in H1, the 1.3% growth was entirely volume driven — that is a cleaner read than it first looks.Riding a Wave the Market Already Left
Here is the contrast that matters. Sarantis's cost problem — fuel, freight, Middle East — is a shared global theme, not a company-unique one. On the market-wide tape, high fuel costs ranked near the very top in the 2026-Q2 window, with Middle East conflict and high fuel prices close behind. Other recent reporters confirmed the same squeeze: JILL flagged fuel surcharges, and NWC.TO called out higher fuel cost on freight. But by the latest global quarter (20263), that whole fuel/Middle-East complex has been swept off the top of the board by a completely different narrative: net tariff refunds, tariff refund recovery, and earnings-growth talk now dominate the market's editor-curated keywords. Sarantis, tellingly, says nothing about tariffs at all. In other words, Sarantis is monetarily exposed to the last wave — a cost theme already fading in global mind-share — which is why management's caution reads less like a company-specific stumble and more like a lag: the group's P&L still feels an input shock the broader market has stopped discussing.The War Chest, and One Missing Commitment
The genuinely company-unique thread is M&A. Sarantis is holding future acquisitions firepower:Bouras adds that the deal pipeline has shifted from "theoretical interest" to "more specific processes," disciplined to Eastern Europe and adjacent categories/geographies rather than new frontiers. But on the near-term outlook, management withheld the one number analysts wanted. Asked to confirm confidence in the prior €620M sales / €97M EBITDA guidance, Bouras deflected: “at this moment in time, we cannot commit to a specific number.” — Ioannis K. Bouras, CEO · 2026-09-09 That reticence is a signal — Romania keeps declining (~-5% sales, -17% EBITDA), Ukraine improved to only a €0.7M loss but is warned to worsen, and US export phasing pushed international markets down ~14% before supposed H2 normalization. The offset is that the long-term plan is not in question — Bouras reconfirmed the multi-year target arc (€120M by December 2028, €100M EBIT). And the brand engine is intact: the Carroten brand is progressing on Amazon US and Target, with a new market (Chile) and Australia retailers added. The private label book held flat at €35.2M at breakeven, still deployed tactically as a cost absorber rather than a growth pillar — consistent with management's stated intent to shrink it over time in favour of branded business.we have committed loan facilities of €120 million as a war chest for future acquisitions.